These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25107416)

  • 1. What Is the Appropriate Duration of High-Dose Atorvastatin Therapy Post-Acute Coronary Syndrome?
    Goriacko P; Andersen M; Fazylov R; Plakogiannis R
    J Pharm Pract; 2015 Dec; 28(6):555-60. PubMed ID: 25107416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial.
    Berwanger O; Santucci EV; de Barros E Silva PGM; Jesuíno IA; Damiani LP; Barbosa LM; Santos RHN; Laranjeira LN; Egydio FM; Borges de Oliveira JA; Dall Orto FTC; Beraldo de Andrade P; Bienert IRC; Bosso CE; Mangione JA; Polanczyk CA; Sousa AGMR; Kalil RAK; Santos LM; Sposito AC; Rech RL; Sousa ACS; Baldissera F; Nascimento BR; Giraldez RRCV; Cavalcanti AB; Pereira SB; Mattos LA; Armaganijan LV; Guimarães HP; Sousa JEMR; Alexander JH; Granger CB; Lopes RD;
    JAMA; 2018 Apr; 319(13):1331-1340. PubMed ID: 29525821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.
    Liu Z; Joerg H; Hao H; Xu J; Hu S; Li B; Sang C; Xia J; Chu Y; Xu D
    Ann Pharmacother; 2016 Sep; 50(9):725-33. PubMed ID: 27307415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive Statin Therapy in NSTE-ACS Patients Undergoing PCI: Clinical and Biochemical Effects.
    Shehata M; Fayez G; Nassar A
    Tex Heart Inst J; 2015 Dec; 42(6):528-36. PubMed ID: 26664304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of high intensity atorvastatin versus moderate intensity atorvastatin for acute coronary syndrome patients with diabetes mellitus.
    Liu Z; Xu Y; Hao H; Yin C; Xu J; Li J; Wang Y; Xu D
    Int J Cardiol; 2016 Nov; 222():22-26. PubMed ID: 27448700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [JAPAN-ACS (Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome)].
    Dohi T; Daida H
    Nihon Rinsho; 2016 Jun; 74 Suppl 4 Pt 1():697-702. PubMed ID: 27534254
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome.
    Liu Z; Hao H; Yin C; Chu Y; Li J; Xu D
    Oncotarget; 2017 Jun; 8(25):41582-41589. PubMed ID: 28177908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilisation and maintenance of high-intensity statins following acute coronary syndrome and coronary angiography: opportunities to improve care (ANZACS-QI 26).
    Kerr AJ; Mitnala S; Lee M; White HD
    N Z Med J; 2020 Mar; 133(1511):21-40. PubMed ID: 32161419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial.
    Murphy SA; Cannon CP; Wiviott SD; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2009 Dec; 54(25):2358-62. PubMed ID: 20082923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes.
    Li L; Zhang M; Su F; Li Y; Shen Y; Shen J; Zhang D
    Lipids Health Dis; 2015 Feb; 14():10. PubMed ID: 25879728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of atorvastatin on serum omentin-1 in patients with coronary artery disease.
    Chen Q; Shang X; Yuan M; Liang L; Zhong X
    Coron Artery Dis; 2017 Jan; 28(1):44-51. PubMed ID: 27749321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early, intensive statin treatment reduces 'hard' cardiovascular outcomes after acute coronary syndrome.
    Schwartz GG; Fayyad R; Szarek M; DeMicco D; Olsson AG
    Eur J Prev Cardiol; 2017 Aug; 24(12):1294-1296. PubMed ID: 28504565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.
    Schwartz GG; Bessac L; Berdan LG; Bhatt DL; Bittner V; Diaz R; Goodman SG; Hanotin C; Harrington RA; Jukema JW; Mahaffey KW; Moryusef A; Pordy R; Roe MT; Rorick T; Sasiela WJ; Shirodaria C; Szarek M; Tamby JF; Tricoci P; White H; Zeiher A; Steg PG
    Am Heart J; 2014 Nov; 168(5):682-9. PubMed ID: 25440796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation Activation Contributes to Adipokine Imbalance in Patients with Acute Coronary Syndrome.
    Li R; Chen LZ; Zhao SP; Huang XS
    PLoS One; 2016; 11(3):e0151916. PubMed ID: 26986475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.
    Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2465-72. PubMed ID: 25212234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After Percutaneous Coronary Intervention (HIPOCRATES Study).
    Eisen A; Leshem-Lev D; Yavin H; Orvin K; Mager A; Rechavia E; Bental T; Dadush O; Battler A; Kornowski R; Lev EI
    Cardiovasc Drugs Ther; 2015 Apr; 29(2):129-35. PubMed ID: 25712416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
    Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
    Billings FT; Hendricks PA; Schildcrout JS; Shi Y; Petracek MR; Byrne JG; Brown NJ
    JAMA; 2016 Mar; 315(9):877-88. PubMed ID: 26906014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.